Shandong Xinhua Pharmaceutical Company Limited at the extraordinary general meeting, approved the proposed appointments of (i) Mr. LING Peixue (Mr. Ling) as an independent non- executive director of the Company, (ii) Mr. Xu Wenhui (Mr. Xu) as an executive director of the Company and (iii) Mr. Hou Ning (Mr. Hou) as an executive director of the Company (the Appointments). The Board announced that, the Appointments have been approved at the EGM. Mr. Ling formally serves as an independent non-executive director of the Company from the date of this announcement (27 October 2022) to the expiration date of the term of office of the Tenth Session of the Board until 22 December 2023.

In addition, each of Mr. Xu and Mr. Hou formally serves as an executive director of the Company from the date of this announcement (from 27 October 2022) to the expiration date of the term of office of the Tenth Session of the Board until 22 December 2023.